This company is no longer active
The company may no longer be operating, as it may be out of business. Find out why through their latest events.
Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Belohnungen
Risikoanalyse
+ 3 mehr Risiken
Tricida, Inc. Wettbewerber
Preisentwicklung & Leistung
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.00001 |
| 52 Week High | US$13.85 |
| 52 Week Low | US$0.00001 |
| Beta | 0.051 |
| 1 Month Change | -99.89% |
| 3 Month Change | -99.93% |
| 1 Year Change | -100.00% |
| 3 Year Change | -100.00% |
| 5 Year Change | n/a |
| Change since IPO | -100.00% |
Aktuelle Nachrichten und Updates
Recent updates
Tricida enters $125M debt facility
Oct 19Tricida: Important Binary Event Coming Up
Sep 21Calculating The Intrinsic Value Of Tricida, Inc. (NASDAQ:TCDA)
Sep 14
Insider Buying: The Tricida, Inc. (NASDAQ:TCDA) CFO & Executive VP Just Bought 6.5% More Shares
Dec 14Tricida revises VALOR-CKD trial protocol, updates patent protection, shares down 14%
Dec 09Tricida's Veverimer CRL And Regulatory Updates: An Analysis
Nov 17Tricida slumps 46% on FDA feedback on veverimer proposal; launches cost-cutting initiatives
Oct 29Aktionärsrenditen
| TCDA.Q | US Pharmaceuticals | US Markt | |
|---|---|---|---|
| 7D | -99.9% | 2.4% | 0.8% |
| 1Y | -100.0% | 18.3% | 22.5% |
Rendite im Vergleich zur Industrie: TCDA.Q underperformed the US Pharmaceuticals industry which returned 6.4% over the past year.
Rendite vs. Markt: TCDA.Q underperformed the US Market which returned 14% over the past year.
Preisvolatilität
| TCDA.Q volatility | |
|---|---|
| TCDA.Q Average Weekly Movement | 43.8% |
| Pharmaceuticals Industry Average Movement | 9.9% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 2.8% |
Stabiler Aktienkurs: TCDA.Q's share price has been volatile over the past 3 months.
Volatilität im Zeitverlauf: TCDA.Q's weekly volatility has increased from 31% to 44% over the past year.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 2013 | 57 | Gerrit Klaerner | www.tricida.com |
Tricida, Inc.'s Grundlagenzusammenfassung
| TCDA.Q grundlegende Statistiken | |
|---|---|
| Marktanteil | US$580.00 |
| Gewinn(TTM) | -US$133.91m |
| Umsatz(TTM) | n/a |
0.0x
Kurs-Umsatz-Verhältnis0.0x
Kurs-Gewinn-VerhältnisIst TCDA.Q zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| TCDA.Q Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | US$0 |
| Kosten der Einnahmen | US$0 |
| Bruttogewinn | US$0 |
| Sonstige Ausgaben | US$133.91m |
| Umsatz | -US$133.91m |
Zuletzt gemeldete Gewinne
Sep 30, 2022
Datum des nächsten Gewinnberichts
k.A.
| Gewinn per Aktie (EPS) | -2.31 |
| Bruttomarge | 0.00% |
| Nettogewinnspanne | 0.00% |
| Schulden/Eigenkapital-Verhältnis | -143.5% |
Wie hat sich TCDA.Q auf lange Sicht entwickelt?
Historische Performance und Vergleiche